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Immunological protection, acquired
from either natural infection or vaccina-
tion, varies among hosts, reflecting under-
lying biological variation and affecting
population-level protection. Owing to the
nature of resistance mechanisms, distribu-
tions of susceptibility and protection en-
tangle with pathogen dose in a way that
can be decoupled by adequately repre-
senting the dose dimension. Any infectious
processes must depend in some fashion on
dose, and empirical evidence exists for an
effect of exposure dose on the probability
of transmission to mumps-vaccinated hosts
[1], the case-fatality ratio of measles [2],
and the probability of infection and, given
infection, of symptoms in cholera [3].
Extreme distributions of vaccine protec-
tion have been termed leaky (partially
protects all hosts) and all-or-nothing (to-
tally protects a proportion of hosts) [4].
These distributions can be distinguished in
vaccine field trials from the time depen-
dence of infections [5]. Frailty mixing
models have also been proposed to
estimate the distribution of protection
from time to event data [6,7], although
the results are not comparable across
regions unless there is explicit control for
baseline transmission [8]. Distributions of
host susceptibility and acquired protection
can be estimated from dose-response data
generated under controlled experimental
conditions [9–11] and natural settings
[12,13]. These distributions can guide
research on mechanisms of protection, as
well as enable model validity across the
entire range of transmission intensities. We
argue for a shift to a dose-dimension
paradigm in infectious disease science
and community health.
Natural Transmission
We consider a minimal susceptible (S)
and infected (I) model [14] of pathogen
transmission in a host population to
explore population effects of protection
conferred by a vaccine (or other preven-
tive measure, such as symbionts) against
infection, under different assumptions
about how this is distributed among
individuals. We consider that infection is
lifelong, and that there is no naturally
acquired immunity.
Vaccines that provide leaky protection
against infection act by reducing suscepti-
bility to a factor s that is distributed
among individuals according to a proba-
bility density function q(x), where
0vxv1. Denoting by iv(x) the densities
of hosts who are vaccinated and have
susceptibility factor x, the integral
Iv~
Ð 1
0
iv(x) dx represents the proportion
of hosts who are infected despite being
vaccinated. Assuming no effect on infec-
tiousness, the per capita rate of infection
among totally susceptible individuals is
given by l~b IzIvð Þ, where b is the
effective contact rate.
Figure 1A shows, for the distributions
q(x) represented on the right, equilibrium
curves describing prevalence of infection
versus transmission intensity measured by
R0, the basic reproduction number. The
curves for extreme cases of vaccines that
confer equal protection to all or total
protection to some and none to others are
depicted by the higher (red) and lower (blue)
curves, respectively. Intermediate curves
represent scenarios in which susceptibility
follows a beta distribution with fixed mean
and increasing variance from top to bottom.
Prevalence curves become shallower with
heterogeneity and converge to the same
level as transmission increases, except in the
all-or-nothing extreme, in which the
prevalence cannot surpass the susceptible
fraction, irrespective of transmission inten-
sity. Although the impact of protection
appears to increase with polarization of
effects, the endemic curves do not converge
uniformly to their all-or-nothing homo-
logue. In the absence of unequivocal
empirical evidence for the idealized all-or-
nothing mode of action, we suggest modi-
fying the terminology to include polarized
distributions more generally.
This illustration indicates that the distri-
bution of vaccine effects among individuals
is a major determinant of population-level
impact and should be considered in
evaluation. Specifically, the more homoge-
neously a vaccine acts, the lower its impact
on disease transmission. Measures based on
multipopulation study designs, spanning a
range of transmission intensities, enable the
inference of such distributions.
Experimental Challenge
Infection in a controlled experimental
setting is modeled by describing infected
proportions in terms of challenge dose.
Adopting standard formulations [15–17],
the mean number of infecting pathogens
is , where d is the number of pathogens
challenging the host, and p is the proba-
bility of infection for each pathogen; the
number of infecting pathogens per host
has a Poisson distribution with mean pd.
In the homogeneous case, the probability
Citation: Gomes MGM, Lipsitch M, Wargo AR, Kurath G, Rebelo C, et al. (2014) A Missing Dimension in
Measures of Vaccination Impacts. PLoS Pathog 10(3): e1003849. doi:10.1371/journal.ppat.1003849
Editor: Glenn F. Rall, The Fox Chase Cancer Center, United States of America
Published March 6, 2014
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted,
modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under
the Creative Commons CC0 public domain dedication.
Funding: This research was supported by the Portuguese Foundation for Science and Technology (FCT), the
European Commission (EC-ICT-231807). CR was supported by FCT, PEst, OE/MAT/UI0209/2011 and project
PTDC/MAT/113383/2009. ML was supported by Award Number U54GM088558 from the National Institute of
General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily
represent the official views of the National Institute of General Medical Sciences or the National Institutes of
Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ggomes@igc.gulbenkian.pt
PLOS Pathogens | www.plospathogens.org 1 March 2014 | Volume 10 | Issue 3 | e1003849
 pd
of a host remaining uninfected after
pathogen challenge is the zero term of
the distribution, leading to a probability of
infectionM~1{e{pd , represented by the
black curve in Figure 1B.
This model fails to fit many experimen-
tal data sets in which groups of hosts are
exposed to varying doses of the pathogen,
and the proportion infected in each group
is calculated. In particular, the slope of the
curve implied by this model is steeper than
what is often observed. However, if indi-
vidual hosts vary in their susceptibility to
infection, a reduced slope arises. A simple
model [11] assumes that the probability of
each particle causing infection varies
among hosts according to a beta distribu-
tion q(x), akin to the vaccine protection
factor above, resulting in the modified dose-
response M~1{
Ð 1
0
e{xpd q(x) dx.
Figure 1B illustrates dose-infectivity
curves expected from an experiment in
which groups of naive and vaccinated hosts
are challenged with a range of pathogen
doses under the distributions of protection
described above, uncovering again a lack of
uniform convergence to the all-or-nothing
formulation.
We have adopted the same notation,
q(x), for susceptibility distributions in both
natural transmission and experimental
challenge settings to indicate the linkage
between two arms of a unified study, as
advocated here.
Classification of Intervention
Effects
Experimental dose-infectivity curves
provide information to infer the mode of
action of interventions, such as vaccines.
Given the lack of uniform convergence to
all-or-nothing as the leaky mode becomes
increasingly polarized, we have classified
beta distribution shapes according to
polarization (Figure 2). The dashed line
along the diagonal indicates the location of
the symmetric distributions used in
Figure 1, and the circles indicate the
location of the extreme homogeneous
(red) and all-or-nothing (blue) distribu-
tions. The power to identify polarized
distributions is analyzed in Figure S1,
focusing on a vicinity of the uniform shape
(gray square), showing good discriminato-
ry power in the region of parameter space
where uncertainty is greatest. This analysis
suggests a promising approach for classi-
fying intervention effects in controlled
experimental settings and using this as
Figure 1. Decreasing infection with heterogeneity in host protection. (A) Equilibrium prevalence of infection under a pathogen transmission
model in which an intervention (vaccine or symbiont) reduces host susceptibility to a factor that is distributed as specified. The model is formally
represented by the rates of change in the proportions of the population that are susceptible and infected: dS=dt~ 1{vð Þm{lS{mS,
dI=dt~lS{mI , dsv(x)=dt~vq(x)m{xlsv(x){msv(x), and div(x)=dt~xlsv(x){miv(x), where S and I are nonintervention, while sv(x) and iv(x) are
intervention groups with susceptibility x distributed as q(x) (right panels). Colored lines assume total intervention coverage (v~1), while the black
line represents the scenario without intervention (v~0). (B) Dose-response curves expected from an experiment in which groups of naive (black) and
intervention (colored) hosts are challenged with a range of pathogen doses, under a model in which the intervention reduces susceptibility to a
factor that is distributed as in panels on the right. Models for infected proportions in nonintervention and intervention groups are formalized in a
dose-response manner by M~1{e{pd and M~1{
Ð 1
0 e
{xpd q(x) dx, respectively, where d is the number of pathogens the host is challenged by
and p is the probability of infection for each pathogen. Colored lines assume susceptibility factors distributed with mean 0.5 in all cases and variance
0 (red), 0.05 (orange), 0.1 (green), 0.2 (cyan), and 0.25 (blue). Red and blue at the extremes are discrete, while the intermediate cases are continuous
beta distributions, with shape parameters a and b such that the mean is fixed,E s½ ~a=(azb)~0:5, and the variance, var s½ ~ab(azb)2 azbz1ð Þ,
spans the range, 0vvar s½ v0:25. Transmission models assume m~0:014, and controlled infection models assume p~10{6 .
doi:10.1371/journal.ppat.1003849.g001
PLOS Pathogens | www.plospathogens.org 2 March 2014 | Volume 10 | Issue 3 | e1003849
prior information for further study in
natural settings [18].
Supporting Information
Figure S1 Power analysis to identify
polarized intervention effects. Simulated
sets of dose-infectivity data were generated
and used to estimate model parameters
(Figure S2), assuming the host susceptibility
of the intervention group described by a
beta distribution, q(x), with shape param-
eters positioned as a grid in a square
neighborhood of the uniform distribution,
0:1ƒa,bƒ10. The procedure was applied
100 times to each of 1,600 grip points, and
the number of correct shape classifications
into polarized (a,bv1) versus non-polar-
ized (aw1 or bw1) is represented. With 50
hosts per dose, the shape was identified with
95% accuracy in 57% of the simulated
parameter space.
(TIFF)
Figure S2 Simulation and estimation
experiment. A simulated set of dose-
infectivity data was generated using
models M~1{e{pd and M~
1{
Ð 1
0
e{xpd q(x) dx for nonintervention
and intervention groups, respectively,
where d is the dose (simulated at 104,
105, 106, 107, 108, 109, and 1010) and p is
the probability of infection for each
pathogen (simulated at 1026). The host
susceptibility of the intervention group is
described by a beta distribution, q(x), with
shape parameters a~b~0:5. By fitting
the models to the simulated data by a least
squares procedure, we have estimated
p~0:86|10{6, a~0:42, and b~0:18.
(A) The nonintervention arm of the
experiment in black and the intervention
arm in green. (B) Intervention effects’
assumed distribution, shown as a dashed
line, and the estimated distribution, rep-
resented as an unbroken line. This is an
example in which a polarized intervention
effect was estimated correctly.
(TIFF)
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Figure 2. Shape classification in the terms of parameters a and b. Beta distributions are
classified as: polarized if a,bv1; symmetric if a~b (gray dashed line), as in Figure 1; homogeneous
in the limit a,b?? (red circle), as red in Figure 1; all-or-nothing in the limit a,b?0 (blue circle), as
blue in Figure 1; and uniform if a~b~1 (gray square). The power to identify polarized distributions
is analyzed in a neighborhood of the uniform distribution (Figure S1).
doi:10.1371/journal.ppat.1003849.g002
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